vimarsana.com

Latest Breaking News On - David glendenning cogan professor - Page 3 : vimarsana.com

Gene associated with Alzheimer s risk could promise treatment strategy to prevent vision loss

Gene associated with Alzheimer s risk could promise treatment strategy to prevent vision loss
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Genetic variant associated with Alzheimer s disease plays a role in protecting against glaucoma

New research led by scientists at Mass Eye and Ear and Brigham and Women's Hospital, member hospitals of Mass General Brigham, reveals the role that a genetic variant associated with Alzheimer's disease, APOE4, plays in protecting against glaucoma.

Wearable devices can reduce collision risk in blind and visually impaired people

Wearable devices can reduce collision risk in blind and visually impaired people
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

New gene-based vaccine strategy receives grant from the Bill & Melinda Gates Foundation

New gene-based vaccine strategy receives grant from the Bill & Melinda Gates Foundation The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million from the Bill & Melinda Gates Foundation. The grant will aid the effort to bring further preclinical validation to the AAV vaccine platform. An AAVCOVID vaccine candidate is set to enter clinical trials in 2021. The AAVCOVID vaccine program was founded at Mass General Brigham at the outset of the pandemic. Preliminary tests of the vaccines stability and potency at different temperatures revealed that AAVCOVID candidates remained potent and effective when stored at room temperature for up to one month. This room temperature stability and the fact AAVCOVID vaccines do not require cold-chain freezer storage, could enable this AAV-based platform to develop a vaccine for COVID-19 and other diseases for developing countries without the n

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.